Texas Treasury Safekeeping Trust CO Genprex, Inc. Transaction History

Texas Treasury Safekeeping Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 07, 2020	SELL	$0.24 - $0.75 $296,452 - $926,414	-1,235,219 Closed	0 $0
Q2 2019 Oct 07, 2019	BUY	$1.2 - $1.85 $1.48 Million - $2.29 Million	1,235,219 New	1,235,219 $1.53 Million
Q2 2019 Aug 13, 2019	SELL	$1.2 - $1.85 $221,756 - $341,874	-184,797 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$4.7 - $4.7 $868,545 - $868,545	184,797 New	184,797 $868,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $43.2M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Texas Treasury Safekeeping Trust CO, based on Form 13F filings with the SEC.

Stay updated on Texas Treasury Safekeeping Trust CO with notifications on news.